Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- BIOG-B.ST
- Price
- 98.35
- Stock movement down
- -0.20 (-0.20%)
- Company name
- BioGaia AB (publ)
- Exchange
- (ST ,
- Currency
- SEK )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 9.59B
- Ent value
- 8.76B
- Price/Sales
- 7.07
- Price/Book
- 5.92
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- 190.83%
- Trailing P/E
- 28.46
- Forward P/E
- 22.71
- PEG
- -
- EPS growth
- -21.83%
- 1 year return
- -14.85%
- 3 year return
- 60.11%
- 5 year return
- 39.50%
- 10 year return
- 27.69%
Last updated: 2025-04-12
DIVIDENDS
BIOG-B.ST does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 28.46 |
| Price to OCF | 24.40 |
| Price to FCF | 26.25 |
| Price to EBITDA | 18.75 |
| EV to EBITDA | 17.13 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 7.07 |
| Price to Book | 5.92 |
| EV to Sales | 6.46 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 97.46M |
| EPS (TTM) | 3.33 |
| FCF per share (TTM) | 3.61 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 1.36B |
| Gross profit (TTM) | 997.60M |
| Operating income (TTM) | 394.38M |
| Net income (TTM) | 336.82M |
| EPS (TTM) | 3.33 |
| EPS (1y forward) | 4.33 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 73.59% |
| Operating margin (TTM) | 29.09% |
| Profit margin (TTM) | 24.85% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 1.11B |
| Net receivables | 0.00 |
| Total current assets | 1.50B |
| Goodwill | 160.69M |
| Intangible assets | 390.00K |
| Property, plant and equipment | 0.00 |
| Total assets | 1.90B |
| Accounts payable | 0.00 |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 192.36M |
| Total liabilities | 285.12M |
| Shareholder's equity | 1.62B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 392.86M |
| Capital expenditures (TTM) | 27.73M |
| Free cash flow (TTM) | 365.13M |
| Dividends paid (TTM) | 696.78M |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 20.79% |
| Return on Assets | 17.68% |
| Return on Invested Capital | 20.79% |
| Cash Return on Invested Capital | 22.54% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 97.70 |
| Daily high | 98.85 |
| Daily low | 95.50 |
| Daily Volume | 103K |
| All-time high | 134.70 |
| 1y analyst estimate | 165.00 |
| Beta | 0.59 |
| EPS (TTM) | 3.33 |
| Dividend per share | - |
| Ex-div date | 8 May 2024 |
| Next earnings date | 5 May 2025 |
Downside potential
Loading...
Downside potential data
| BIOG-B.ST | S&P500 | |
| Current price drop from All-time high | -26.99% | -12.89% |
| Highest price drop | -97.73% | -56.47% |
| Date of highest drop | 10 Oct 2002 | 9 Mar 2009 |
| Avg drop from high | -65.44% | -11.07% |
| Avg time to new high | 129 days | 12 days |
| Max time to new high | 3488 days | 1805 days |
COMPANY DETAILS
Marketcap
9.59B
Marketcap category
Mid-cap
Description
BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was incorrporated in 1990 and is based in Stockholm, Sweden.
Employees
222
Website
Investor relations
-
SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
As European markets navigate the challenges of new U.S. trade tariffs and fluctuating economic indicators, investors are keenly observing opportunities that may arise in the dividend stock segment. In...
April 2, 2025
In March 2025, the European market is navigating a complex landscape characterized by concerns over U.S. trade tariffs, economic growth uncertainties, and fluctuating monetary policies. Despite these ...
March 19, 2025
As the pan-European STOXX Europe 600 Index recently experienced a decline amid concerns over U.S. trade tariffs and monetary policy uncertainties, investors are increasingly seeking opportunities in s...
March 18, 2025
As global markets navigate through a period of heightened inflation and interest rate volatility, U.S. stock indexes are climbing toward record highs, buoyed by strong performance in growth stocks and...
February 18, 2025
As global markets experience fluctuations with U.S. stock indexes nearing record highs and inflation concerns impacting rate expectations, investors are keenly observing the performance of high-growth...
February 18, 2025
In the current market landscape, major indices like the S&P 500 are reaching new highs, buoyed by optimism surrounding potential trade deals and AI advancements. While large-cap stocks have been in th...
January 30, 2025
In recent weeks, global markets have experienced a notable upswing, driven by easing core U.S. inflation and robust bank earnings that have propelled major U.S. stock indexes higher. This positive mom...
January 20, 2025
As global markets navigate a mix of rising stock indices and declining consumer confidence, investors are increasingly focused on strategies that offer stability amidst economic uncertainty. In this e...
January 1, 2025
As global markets navigate a period of mixed economic signals, with U.S. consumer confidence dipping and durable goods orders declining, investors remain cautious yet optimistic about potential opport...
January 1, 2025
As global markets navigate a complex landscape marked by central bank rate cuts and mixed economic indicators, the technology-heavy Nasdaq Composite has reached new heights, contrasting with the under...
December 20, 2024
Next page